Peter R. Hoffmann to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Peter R. Hoffmann has written about Xenograft Model Antitumor Assays.
Connection Strength
0.191
-
Marciel MP, Rose AH, Martinez V, Horio DT, Hashimoto AS, Hoffmann FW, Bertino P, Hoffmann PR. Calpain-2 inhibitor treatment preferentially reduces tumor progression for human colon cancer cells expressing highest levels of this enzyme. Cancer Med. 2018 01; 7(1):175-183.
Score: 0.143
-
Lokman NA, Elder AS, Ween MP, Pyragius CE, Hoffmann P, Oehler MK, Ricciardelli C. Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Oncotarget. 2013 Aug; 4(8):1199-211.
Score: 0.026
-
H?lper P, Schulz-Schaeffer W, Dullin C, Hoffmann P, Harper J, Kurtzberg L, Lonning S, Kugler W, Lakomek M, Erdlenbruch B. Tumor localization of an anti-TGF-? antibody and its effects on gliomas. Int J Oncol. 2011 Jan; 38(1):51-9.
Score: 0.022